| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group. | Pediatr Blood Cancer | 2015 | 0.78 |
| 2 | miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group. | Pediatr Blood Cancer | 2016 | 0.76 |
| 3 | Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. | Clin Cancer Res | 2015 | 0.75 |
| 4 | Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group. | Pediatr Blood Cancer | 2017 | 0.75 |
| 5 | Disease Characteristics and Prognostic Implications of Cell Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. | Clin Cancer Res | 2017 | 0.75 |